1. 2022
  2. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells

    Uthman, L., Li, X., Baartscheer, A., Schumacher, C. A., Baumgart, P., Hermanides, J., Preckel, B., Hollmann, M. W., Coronel, R., Zuurbier, C. J. & Weber, N. C., Feb 2022, In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 146, 112515.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2020
  4. Structurally Abnormal Myocardium Underlies Ventricular Fibrillation Storms in a Patient Diagnosed With the Early Repolarization Pattern

    Boukens, B. J., Benjacholamas, V., van Amersfoort, S., Meijborg, V. M., Schumacher, C., Jensen, B., Haissaguerre, M., Wilde, A., Prechawat, S., Huntrakul, A., Nademanee, K. & Coronel, R., 26 Oct 2020, In: JACC: Clinical Electrophysiology. 6, 11, p. 1395-1404 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2019
  6. Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts

    Uthman, L., Nederlof, R., Eerbeek, O., Baartscheer, A., Schumacher, C., Buchholtz, N., Hollmann, M. W., Coronel, R., Weber, N. C. & Zuurbier, C. J., 1 Aug 2019, In: Cardiovascular research. 115, 10, p. 1533-1545 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2018
  8. Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

    Uthman, L., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T., Kuschma, M. C., Hollmann, M. W., Coronel, R., Weber, N. C. & Zuurbier, C. J., 21 Nov 2018, In: Frontiers in physiology. 9, 1575.

    Research output: Contribution to journalReview articleAcademicpeer-review

  9. 2017
  10. Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits

    Baartscheer, A., Schumacher, C. A., Wüst, R. C. I., Fiolet, J. W. T., Stienen, G. J. M., Coronel, R. & Zuurbier, C. J., 2017, In: Diabetologia. 60, 3, p. 568-573

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2016
  12. Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart

    Nederlof, R., Gürel-Gurevin, E., Eerbeek, O., Xie, C., Deijs, G. S., Konkel, M., Hu, J., Weber, N. C., Schumacher, C. A., Baartscheer, A., Mik, E. G., Hollmann, M. W., Akar, F. G. & Zuurbier, C. J., 2016, In: Journal of physiology and biochemistry. 73, 3, p. 323-333

    Research output: Contribution to journalArticleAcademicpeer-review

  13. 2015
  14. Dyscholesterolemia Protects Against Ischemia-Induced Ventricular Arrhythmias

    Baartscheer, A., Schumacher, C. A., Wekker, V., Verkerk, A. O., Veldkamp, M. W., van Oort, R. J., Elzenaar, I., Ottenhoff, R., van Roomen, C., Aerts, H. & Coronel, R., 2015, In: Circulation. Arrhythmia and electrophysiology. 8, 6, p. 1481-1490

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 Next

ID: 84254